Enhabit, Inc. (NYSE:EHAB) Forecasted to Post FY2025 Earnings of $1.51 Per Share

Enhabit, Inc. (NYSE:EHABGet Rating) – Analysts at Oppenheimer issued their FY2025 earnings estimates for Enhabit in a research report issued on Thursday, January 19th. Oppenheimer analyst M. Wiederhorn anticipates that the company will post earnings per share of $1.51 for the year. Oppenheimer currently has a “Market Perform” rating on the stock. The consensus estimate for Enhabit’s current full-year earnings is $1.45 per share.

Enhabit (NYSE:EHABGet Rating) last posted its quarterly earnings results on Tuesday, November 1st. The company reported $0.19 earnings per share for the quarter, missing the consensus estimate of $0.28 by ($0.09). The business had revenue of $265.70 million during the quarter, compared to analysts’ expectations of $265.62 million. Enhabit had a return on equity of 7.62% and a net margin of 7.76%.

Other equities research analysts have also recently issued reports about the stock. Stifel Nicolaus assumed coverage on shares of Enhabit in a research report on Monday, December 5th. They set a “buy” rating and a $17.00 price objective for the company. CJS Securities started coverage on shares of Enhabit in a report on Tuesday, December 13th. They issued a “market perform” rating and a $18.00 price objective for the company. UBS Group started coverage on shares of Enhabit in a report on Thursday, December 8th. They issued a “sell” rating and a $12.00 price objective for the company. Finally, Credit Suisse Group dropped their price objective on shares of Enhabit from $19.00 to $15.00 and set a “neutral” rating for the company in a report on Friday, November 4th. Two equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $16.43.

Enhabit Stock Up 2.5 %

Enhabit stock opened at $15.37 on Friday. Enhabit has a 12-month low of $11.65 and a 12-month high of $25.25. The company has a 50-day moving average price of $13.44 and a 200 day moving average price of $14.44. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.50 and a current ratio of 1.50.

Institutional Trading of Enhabit

Several institutional investors have recently modified their holdings of the stock. Bessemer Group Inc. purchased a new stake in Enhabit in the 3rd quarter valued at $26,000. CI Investments Inc. purchased a new stake in Enhabit in the 2nd quarter valued at $27,000. Lazard Asset Management LLC purchased a new stake in Enhabit in the 3rd quarter valued at $34,000. IFP Advisors Inc purchased a new stake in Enhabit in the 3rd quarter valued at $39,000. Finally, South Dakota Investment Council acquired a new position in Enhabit in the 3rd quarter valued at $45,000. Hedge funds and other institutional investors own 95.55% of the company’s stock.

Insider Buying and Selling

In other news, Director Gregory S. Rush purchased 8,300 shares of the firm’s stock in a transaction that occurred on Monday, November 7th. The stock was bought at an average price of $12.69 per share, for a total transaction of $105,327.00. Following the completion of the purchase, the director now directly owns 16,597 shares of the company’s stock, valued at $210,615.93. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, Director Jeffrey Bolton acquired 2,000 shares of Enhabit stock in a transaction dated Wednesday, November 9th. The stock was acquired at an average price of $12.75 per share, for a total transaction of $25,500.00. Following the transaction, the director now owns 14,597 shares of the company’s stock, valued at $186,111.75. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Gregory S. Rush acquired 8,300 shares of Enhabit stock in a transaction dated Monday, November 7th. The shares were bought at an average price of $12.69 per share, with a total value of $105,327.00. Following the transaction, the director now directly owns 16,597 shares in the company, valued at approximately $210,615.93. The disclosure for this purchase can be found here. Insiders bought 13,000 shares of company stock worth $164,903 over the last 90 days.

Enhabit Company Profile

(Get Rating)

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.

See Also

Receive News & Ratings for Enhabit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enhabit and related companies with MarketBeat.com's FREE daily email newsletter.